3 VAN DE GRAAFF DRIVE, BURLINGTON, MA
Earnings Release
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Completes Randomization in REMAIN-1 Pivotal Cohort of Revita® for Post-GLP-1 Weight Maintenance
Investor Presentation
Appoints Lara Smith Weber as Chief Financial Officer to Support Commercial-Stage Preparedness
Enters a Catalyst-Rich 2026 Positioned to Define the Post-GLP-1 Weight Maintenance Therapeutic Category
Call Notice for All Tranche A Common Stock Purchase Warrants
Reports Positive 6-Month REVEAL-1 Open-Label Results Showing Sustained Post-GLP-1 Weight Maintenance After a Single Revita® Procedure
FY 2025
Q3
Q2
Q1
FY 2024
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Amended Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
SEC Staff Correspondence
Correspondence